📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: XinThera

1.1 - Company Overview

XinThera Logo

XinThera

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of drug discovery focused on building a small molecule oncology and immunology pipeline.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to XinThera

SonoCiné Logo

SonoCiné

HQ: United States Website
  • Description: Provider of an imaging solution for breast cancer screening, which the company develops and markets.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full SonoCiné company profile →
ProNova Solutions Logo

ProNova Solutions

HQ: United States Website
  • Description: Provider of compact proton therapy systems and project development services for cancer treatment. Offers the ProNova SC360 with pencil beam scanning and cone-beam CT imaging, leveraging superconducting magnet technology in the cyclotron and treatment gantry, and supports design, construction, equipment installation, commissioning, and clinical start-up of proton therapy centers.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ProNova Solutions company profile →
NuView Life Sciences Logo

NuView Life Sciences

HQ: United States Website
  • Description: Provider of medical imaging and diagnostic solutions leveraging the NV-VPAC1 peptide to target VPAC1 receptors for PET imaging and theranostic applications. Offers in vitro urine-based diagnostic kits for detecting prostate and bladder cancer, in vivo PET agents for diagnosing breast and prostate cancer, and peptide-guided delivery of isotopes (e.g., Copper-64 for imaging, Copper-67 for treatment).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NuView Life Sciences company profile →
AnPac Bio Logo

AnPac Bio

HQ: United States Website
  • Description: Provider of early cancer screening and detection services, offering the CDA Early Cancer Risk Assessment using Cancer Differentiation Analysis to evaluate early cancer risks, the APCS Pan-Cancer Screening to detect multiple cancer types, and the ADME Third Immune Defense Test to assess immune defense capabilities against diseases, including cancer.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full AnPac Bio company profile →
F-star Logo

F-star

HQ: United Kingdom Website
  • Description: Provider of novel bispecific antibody therapeutics focused on immuno-oncology and oncology, developing bispecific antibody products to improve the standard of care, with the ability to create and develop Fcab™ antibody fragments.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full F-star company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for XinThera

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to XinThera

2.2 - Growth funds investing in similar companies to XinThera

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for XinThera

4.2 - Public trading comparable groups for XinThera

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to XinThera

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About XinThera

What does XinThera do?

XinThera is a provider of drug discovery focused on building a small molecule oncology and immunology pipeline.

Who are XinThera's competitors?

XinThera's competitors and similar companies include SonoCiné, ProNova Solutions, NuView Life Sciences, AnPac Bio, and F-star.

Where is XinThera headquartered?

XinThera is headquartered in United States.

How many employees does XinThera have?

XinThera has 1,000 employees 🔒.

When was XinThera founded?

XinThera was founded in 2010 🔒.

What sector and industry vertical is XinThera in?

XinThera is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for XinThera

Who are the top strategic acquirers in XinThera's sector and industry

Top strategic M&A buyers and acquirers in XinThera's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for XinThera?

Top strategic M&A buyers groups and sectors for XinThera include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in XinThera's sector and industry vertical

Which are the top PE firms investing in XinThera's sector and industry vertical?

Top PE firms investing in XinThera's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in XinThera's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in XinThera's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in XinThera's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to XinThera include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in XinThera's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for XinThera?

The key public trading comparables and valuation benchmarks for XinThera include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for XinThera for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for XinThera with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in XinThera's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for XinThera with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in XinThera's' sector and industry vertical?

Access recent funding rounds and capital raises in XinThera's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for XinThera